Thu, Apr 25, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Industry Updates

Healthcare hedge funds decline 22.1% YTD but are well-placed to capitalize on current trends and grow returns

Tuesday, November 01, 2022
Opalesque Industry Update - The first nine months of 2022 have been exceptionally challenging for the global financial markets, with rising geopolitical tensions, inflation, interest rates, recession concerns and the emergence of new, more transmissible variants of Covid-19 among an evergrowing list of worries that investors must grapple with, causing a spike in market volatility that has seen the CBOE Volatility Index rise 83.6% this year.

Against this backdrop, the average healthcare hedge fund declined 22.1%, a disappointing return but still superior to the 24.8% fall of the S&P 500.

Nevertheless, healthcare hedge funds have performed exceptionally well over the long-term. With the Covid-19 pandemic driving increased global awareness of the importance of effective pandemic preparedness, aging demographics across most developed countries and healthcare's generally low correlation with global macro conditions, healthcare hedge funds are well-placed to capitalize on these trend to grow returns and fortify their investments.

The average healthcare hedge fund has declined 22.1% YTD. Despite the disappointing return, this is still superior to the 24.8% fall of the S&P 500.

Healthcare hedge funds have generated returns exceeding 10% during fourteen of the twenty-two years prior to 2022. However, they have declined 22.1% over the first 9 months of 2022, weighed down by the bearish market sentiment that has seen the S&P 500 and NASDAQ composite lose 24.8% and 32.4%, respectively.

Healthcare hedge funds (33.3%) have performed exceptionally well in 2020 as the onset of the Covid-19 pandemic incited a boom in the sector, outperforming the average hedge fund and the S&P 500 by 20.0% and 17.0%, respectively. This margin of outperformance was last witnessed in 2008 when the average healthcare hedge fund outperformed the S&P 500 by 22.4%. However, the positive trend of outperformance reversed in 2021 with healthcare hedge funds managing to return 2.3% versus the S&P 500's 26.9%.

Since the end of 1999, the Eurekahedge Healthcare Hedge Fund Index has generated an annualized return of 10.9%, outperforming the Eurekahedge Technology Hedge Fund Index (9.1%), Eurekahedge Hedge Fund Index (8.2%), S&P 500 (4.0%) and NASDAQ Composite (4.3%).

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1